Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31
Phase 42

Trial Status

Completed2
Terminated2

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT05286203Not ApplicableCompleted
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
Infectious DiseaseUveitis
PrincipalinvestigatorStart date: 2022-06-06
NCT04750655Phase 4Completed
Antibiotic Resistance In Eye Surgeries
Antibiotic ResistanceGut ResistomeOcular Surface Microbiome
PrincipalinvestigatorStart date: 2021-03-01
NCT04332107Phase 3Terminated
Azithromycin for COVID-19 Treatment in Outpatients Nationwide
COVID-19SARS-CoV-2
PrincipalinvestigatorStart date: 2020-05-22
NCT03953118Phase 4Terminated
Azithromycin for Meibomian Gland Disease
Depression, AnxietyDry EyeNeuropathic Eye Pain+1 more
PrincipalinvestigatorStart date: 2019-09-01

Research Network

Collaboration Network

9 collaborators·8 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Julie Schallhorn, MD, MS

University of California, San Francisco

Moderately Similar
1 trials

Shared therapeutic areas:

Depression, AnxietyDry EyeNeuropathic Eye Pain+1 more

Worked with same sponsors:

University of California, San Francisco
Collaborated on 1 trial
Similarity Score44%

Ying Han, MD, PhD

University of California, San Francisco

Moderately Similar
3 trials

Shared therapeutic areas:

Antibiotic Resistance, MicrobialGut ResistomeOcular Surface Microbiome

Worked with same sponsors:

Stanford UniversityUniversity of California, San Francisco
Collaborated on 1 trial
Similarity Score34%

Catherine Oldenburg, ScD, MPH

University of California, San Francisco

Related
3 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2

Worked with same sponsors:

Bill and Melinda Gates FoundationPfizer+3 more
Collaborated on 1 trial
Similarity Score24%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2Depression, Anxiety
Similarity Score8%

Matthew J Memoli, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
15 trials

Shared therapeutic areas:

SARS-CoV-2COVID-19
Similarity Score5%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2

Worked with same sponsors:

University of California, Los Angeles
Similarity Score5%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Communicable Diseases
Similarity Score3%

Emily Y Chew, M.D.

National Eye Institute (NEI)

Related
17 trials

Shared therapeutic areas:

Uveitis
Similarity Score3%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Dry Eye
Similarity Score3%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05286203Not ApplicablePrincipalInvestigator

Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing

Infectious DiseaseUveitis
Completed
NCT04750655Phase 4PrincipalInvestigator

Antibiotic Resistance In Eye Surgeries

Antibiotic ResistanceGut ResistomeOcular Surface Microbiome
Completed
NCT04332107Phase 3PrincipalInvestigator

Azithromycin for COVID-19 Treatment in Outpatients Nationwide

COVID-19SARS-CoV-2
Terminated
NCT03953118Phase 4PrincipalInvestigator

Azithromycin for Meibomian Gland Disease

Depression, AnxietyDry EyeNeuropathic Eye Pain+1 more
Terminated

All 4 trials loaded